Health News Roundup: China approves five COVID-19 antigen kits for self-testing – CCTV; South Korea reports record 383,665 new COVID-19 cases – KDCA and more

0

Here is a summary of health news briefs.

China approves five COVID-19 antigen kits for self-testing – CCTV

China has granted approval to five COVID-19 antigen kits made by local companies to be used for self-testing, state broadcaster CCTV said on Saturday, as it changes its testing regime. which has been under pressure from Omicron. China’s National Medical Products Administration (NMPA) on Friday issued a notice that Beijing Huaketai Biotechnology has been authorized to make changes to the device certificate of its COVID-19 antigen test kit.

South Korea reports record 383,665 new COVID-19 cases – Reuters

South Korea has reported a new daily record of 383,665 COVID-19 cases, the Korea Disease Control and Prevention Agency said on Saturday, amid a spike in Omicron infections.

Exclusive-WHO says it advised Ukraine to destroy pathogens in health labs to prevent spread of disease

The World Health Organization has advised Ukraine to destroy high-risk pathogens harbored in the country’s public health laboratories to prevent “any potential spills” that would spread the disease among the population, the report said. agency at Reuters. Like many other countries, Ukraine has public health laboratories studying how to mitigate the threats of dangerous diseases affecting both animals and humans, including, more recently, COVID-19. Its laboratories have received support from the United States, the European Union and the WHO.

US FDA approves AstraZeneca-Merck’s Lynparza to treat early-stage breast cancer

British drugmaker AstraZeneca Plc said the US Food and Drug Administration had approved its cancer drug, jointly developed with US firm Merck & Co, as a treatment for patients with early-stage breast cancer with certain changes. AstraZeneca said on Friday that the drug, Lynparza, was approved for patients with a genetically mutated form of high-risk breast cancer called HER2-negative BRCA-mutated breast cancer who have already been treated with chemotherapy before or after surgery.

The GeoVax vaccine targeting the virus in two places shows promise; the virus can become resistant to antibodies

Here is a summary of some recent studies on COVID-19. They include research that deserves further study to corroborate the findings and that has not yet been certified by peer review. Two vaccine targets on the virus may be better than one

Hong Kong leader Lam says city has yet to pass peak of COVID

Hong Kong reported 27,647 new cases of COVID-19 on Saturday, with city leader Carrie Lam saying the outbreak has yet to pass its peak despite a slight stabilization in recent daily case counts. Health authorities reported 27,647 new positive cases in Hong Kong on Saturday, compared with 29,381 new infections on Friday and 31,402 new cases on Thursday. 198 new deaths have also been reported in the past 24 hours.

Daily local symptomatic COVID cases in China have more than tripled

Mainland China reported 1,807 new local symptomatic cases of COVID-19 on Sunday, more than triple the previous day’s case count and the highest in about two years, as infections spike in a northeastern province compresses health resources. The number of locally transmitted cases with confirmed symptoms reported on Saturday rose sharply from 476 the day before, National Health Commission data showed on Sunday. The 1,807 daily counts included 114 initially classified as asymptomatic who developed symptoms later on Saturday.

Australia moves closer to living with COVID like the flu – PM Morrison

Australian Prime Minister Scott Morrison said the country’s political leaders wanted to move into a new phase of living with COVID-19 as if it were the flu, but would consult with health experts. A day after meeting with the national cabinet of state and federal leaders, Morrison told reporters on Saturday morning that they had discussed moving to “Phase D” of the national pandemic response plan.

France to launch fourth COVID vaccine for over-80s, PM says

France will start offering a fourth COVID-19 vaccine to people over 80 who received their previous booster dose more than three months ago, French Prime Minister Jean Castex told Le Parisien daily in an interview published on Saturday. The Prime Minister had said in January that France was ready to launch a campaign for a fourth vaccine, or second booster, as soon as health authorities gave the green light.

French COVID-19 infections again up 25% week-on-week, trending up again

New COVID-19 infections in France rose by more than 25% on Friday compared to a week ago after rising by more than 24% on Thursday, as a downward trend that had started in late January subsided. is reversed. The Health Ministry recorded 72,399 new infections on Friday, while the seven-day rolling average of new infections also rose, for the fourth day in a row, by almost 16% to more than 60,000.

(With agency contributions.)

Share.

About Author

Comments are closed.